NEW YORK, Aug. 29, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Acute Heart Failure (AHF) Therapeutics Industry
This report analyzes the worldwide markets for Acute Heart Failure (AHF) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, and Rest of Europe) Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 36 companies including many key and niche players such as Abbott Laboratories, Bayer AG, Cardiorentis AG, Cardioxyl Pharmaceuticals, Inc., Cornerstone Therapeutics, Hospira, Inc., Johnson & Johnson, Nile Therapeutics, Inc., Novartis International AG, Orion Corporation, Trevena, Inc., and Valeant Pharmaceuticals International, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
To order this report:
Therapy Industry: Global Acute Heart Failure (AHF) Therapeutics Industry
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article